May 26, 2015
GlaxoSmithKline K.K. (GSK) rolled out the polypeptide antibiotic Aldreb for Injection 150 mg (colistin sodium methanesulfonate) in Japan on May 25. The drug is indicated for infection with colistin-sensitive E. coli, Citrobacter, Klebsiella, Enterobacter, and Acinetobacter bacteria and Pseudomonas aeruginosa...read more